Prevalence and significance of <i>DDX41</i> gene variants in the general population

Sruthi Cheloor Kovilakam(Wellcome/MRC Cambridge Stem Cell Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Clea Bárcena(Universidad de Oviedo), William G. Dunn(Wellcome/MRC Cambridge Stem Cell Institute), Pedro M. Quirós(École Polytechnique Fédérale de Lausanne), Margarete A. Fabre(AstraZeneca (United Kingdom)), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Serena Nik‐Zainal(University of Cambridge), Siddhartha P. Kar(University of Cambridge), Irina Mohorianu(Wellcome/MRC Cambridge Stem Cell Institute), Ludovica Marando(Wellcome/MRC Cambridge Stem Cell Institute)
Blood
July 28, 2023
10.1182/blood.2023020209
Cited by 50

Related Papers

Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Mutational Processes Molding the Genomes of 21 Breast Cancers
|Cell|2012|2k
The landscape of cancer genes and mutational processes in breast cancer
|Nature|2012|1.7k
The Life History of 21 Breast Cancers
|Cell|2012|1.5k